Ad Alert

Canine Care in the Doghouse over Drug Claims

Federal agency's warning letter concerns the marketing of the company's Tumexal product.

Ad Alert

Canine Care in the Doghouse over Drug Claims

The marketer of a canine medication is in the FDA’s doghouse for making drug claims without the agency’s approval. Canine Care makes the online claims that its product, Tumexal, “is effective against a wide array of canine cancers” and “will almost always restore a cancer-stricken dog’s appetite, spirit and energy.” But such treatment claims are reserved for FDA-approved drugs and Tumexal does not hold that distinction, the agency said in a recent warning letter advising Canine Care to drop the claims or else face potential enforcement action.

RELATED: Why you should sit, stay on ThunderShirt


You Might Be Interested In

Amplifei

Ad Alert

Amplifei

A misleading income disclosure statement is just the tip of the iceberg with this supplement MLM.

Doggie Dailies

Ad Alert

Doggie Dailies

Dog supplement manufacturer makes changes to Amazon listing following TINA.org inquiry.